Literature DB >> 9851971

Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes.

E C Holland1, W P Hively, V Gallo, H E Varmus.   

Abstract

Nearly all human gliomas exhibit alterations in one of three genetic loci governing G1 arrest: INK4a-ARF, CDK4, or RB. To discern the roles of CDK4 amplification and INK4a-ARF loss in gliomagenesis, we compared the behavior of astrocytes lacking a functional INK4a-ARF locus with astrocytes overexpressing CDK4. Either a deficiency of p16(INK4a) and p19(ARF) or an increase in Cdk4 allows cultured astrocytes to grow without senescence. Astrocytes overexpressing CDK4 grow more slowly than INK4a-ARF-deficient astrocytes and convert to a tetraploid state at high efficiency; in contrast, INK4a-ARF-deficient cells remain pseudodiploid, consistent with properties observed in human gliomas with corresponding lesions in these genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851971      PMCID: PMC317261          DOI: 10.1101/gad.12.23.3644

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  28 in total

Review 1.  The tumor suppressor genes.

Authors:  A J Levine
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

2.  Immortalization of different precursors of glial cells with a targeted and temperature-sensitive oncogene.

Authors:  R Bernard; M Le Bert; I Borde; E Galiana; C Evrard; P Rouget
Journal:  Exp Cell Res       Date:  1994-09       Impact factor: 3.905

3.  Proliferation and differentiation of rat neuroepithelial precursor cells in vivo.

Authors:  K Frederiksen; R D McKay
Journal:  J Neurosci       Date:  1988-04       Impact factor: 6.167

4.  The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors.

Authors:  J Schaefer-Klein; I Givol; E V Barsov; J M Whitcomb; M VanBrocklin; D N Foster; M J Federspiel; S H Hughes
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

5.  Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells.

Authors:  T Tohyama; V M Lee; L B Rorke; M Marvin; R D McKay; J Q Trojanowski
Journal:  Lab Invest       Date:  1992-03       Impact factor: 5.662

6.  A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.

Authors:  E C Holland; W P Hively; R A DePinho; H E Varmus
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

7.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Authors:  H Matsushime; M E Ewen; D K Strom; J Y Kato; S K Hanks; M F Roussel; C J Sherr
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

8.  CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Authors:  E E Schmidt; K Ichimura; G Reifenberger; V P Collins
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

9.  CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.

Authors:  J He; J R Allen; V P Collins; M J Allalunis-Turner; R Godbout; R S Day; C D James
Journal:  Cancer Res       Date:  1994-11-15       Impact factor: 12.701

10.  p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

Authors:  D J van Meyel; D A Ramsay; A G Casson; M Keeney; A F Chambers; J G Cairncross
Journal:  J Natl Cancer Inst       Date:  1994-07-06       Impact factor: 13.506

View more
  43 in total

1.  Transgenic expression of cyclin-dependent kinase 4 results in epidermal hyperplasia, hypertrophy, and severe dermal fibrosis.

Authors:  P L Miliani de Marval; I B Gimenez-Conti; M LaCava; L A Martinez; C J Conti; M L Rodriguez-Puebla
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  Gene targeting to the stroma of the prostate and bone.

Authors:  Roger S Jackson; Omar E Franco; Neil A Bhowmick
Journal:  Differentiation       Date:  2008-05-20       Impact factor: 3.880

3.  Identification of CDK4 as a target of c-MYC.

Authors:  H Hermeking; C Rago; M Schuhmacher; Q Li; J F Barrett; A J Obaya; B C O'Connell; M K Mateyak; W Tam; F Kohlhuber; C V Dang; J M Sedivy; D Eick; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 4.  Cell senescence and hypermitogenic arrest.

Authors:  Mikhail V Blagosklonny
Journal:  EMBO Rep       Date:  2003-04       Impact factor: 8.807

Review 5.  Animal models of cell cycle dysregulation and the pathogenesis of gliomas.

Authors:  E C Holland
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

6.  RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.

Authors:  Ulrica K Westermark; Nanna Lindberg; Pernilla Roswall; Daniel Bråsäter; Hildur R Helgadottir; Sanna-Maria Hede; Anders Zetterberg; Maria Jasin; Monica Nistér; Lene Uhrbom
Journal:  Neuro Oncol       Date:  2011-09-16       Impact factor: 12.300

7.  Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.

Authors:  Marcelo L Rodriguez-Puebla; Paula L Miliani de Marval; Margaret LaCava; David S Moons; Hiroaki Kiyokawa; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance.

Authors:  William Pao; David S Klimstra; Galen H Fisher; Harold E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

9.  Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.

Authors:  Thomas S Jacques; Alexander Swales; Monika J Brzozowski; Nico V Henriquez; Jacqueline M Linehan; Zaman Mirzadeh; Catherine O' Malley; Heike Naumann; Arturo Alvarez-Buylla; Sebastian Brandner
Journal:  EMBO J       Date:  2009-11-19       Impact factor: 11.598

10.  53BP1 is a haploinsufficient tumor suppressor and protects cells from radiation response in glioma.

Authors:  Massimo Squatrito; Fabio Vanoli; Nikolaus Schultz; Maria Jasin; Eric C Holland
Journal:  Cancer Res       Date:  2012-08-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.